|
Media Releases |
Financial Reports |
Presen-tations |
|
06/09/2006
|
|
|
|
| Lonza announces its intention to dilute its holding in its Polymer Intermediate business; IPO on Italian Stock Exchange (STAR segment) |
Legal Disclaimer: Not for release, publication or distribution in the United States of America, Canada, Japan or Australia. The information contained herein does not constitute an offer of securities for sale in the United States, Canada, Australia or Japan. This press release includes information and warnings set out below regarding its content, use and distribution that should be carefully read and observed.
Lonza Group Ltd. announces its intention to dilute, subject to acceptable market conditions, its holding in the Lonza Polymer Intermediates business via an Initial Public Offering (IPO) of the shares of Lonza SpA which will be renamed “POLYNT SpA”. According to applicable Italian regulations, Lonza SpA has filed a request with Borsa Italiana SpA, the Italian Stock Exchange regulator, for admission to list its shares on the Italian Stock Exchange. Simultaneously, Lonza SpA has filed an application to carry out a related public offering of shares in Italy with Commissione Nazionale per le Società e la Borsa (CONSOB).
POLYNT SpA, one of the leading players in certain sectors of the European polymer intermediates market, plans this initial public offering, and subsequent listing of its shares, on the STAR segment of the Italian Stock Exchange. The authorization from Borsa Italiana S.p.A. and CONSOB is expected in the 3rd quarter of 2006. Mediobanca – Banca di Credito Finanziario S.p.A. is acting as Sponsor of Lonza SpA and Global Co-ordinator of the IPO.
Lonza‘s Polymer Intermediates business, POLYNT SpA, operates in the development, manufacture and marketing of polymers, chemical intermediates and additives used for a vast range of industrial applications including the manufacture of plastics, paints, inks, adhesives, electrical and electronic components, paper and lubricants, as well as resins and composites for the transportation and construction industry.
About Lonza
Lonza, a chemical and biotechnology company driven by the life sciences, generated sales of CHF 2.52 billion in 2005. Headquartered in Switzerland, Lonza operates 22 production and R&D sites around the world. Its 6300 employees are passionately com-mitted to delivering sustainable value to their customers. Lonza is one of the leading custom manufacturers of chemical intermediates, active ingredients and biopharmaceuticals for the pharmaceutical and agrochemical industries. On the basis of organic and performance chemicals and biotechnology platforms, Lonza creates value-added solutions for the nutrition, hygiene & personal care, wood & water treatment and industrial specialty markets. Lonza also offers polymer intermediates, resins and compounds. Lonza is listed on the SWX Swiss Exchange. Further information can be found on our website www.lonza.com.
For further information:
Corporate Communications/Investor Relations
Margot Connor
Tel +41 61 316 8566
Fax +41 61 316 9566
Mobile +41 79 401 2832
margot.connor@lonza.com
This press release is not an offer of securities for sale in the United States. The securities discussed herein have not been and will not be registered under the US Securities Act of 1933, as amended (the "US Securities Act") and may not be offered or sold in the United States absent registration or an exemption from registration under the US Securities Act. No public offering of the securities discussed herein is being made in the United States and the information contained herein does not constitute an offering of securities for sale in the United States, Canada, Australia or Japan. No money, securities or other consideration is being solicited and, if sent in response to the information contained herein, will not be accepted.
This press release is an advertisement and not a prospectus and investors should not subscribe for or purchase any securities referred to in this press release except on the basis of the final prospectus to be published by the issuer in due course.
This press release is only addressed to and directed at persons in member states of the European Economic Area who are "qualified investors" within the meaning of Article 2(1)(e) of the Prospectus Directive (Directive 2003/71/EC)("Qualified Investors"). This press release does not constitute or form part of any offer or invitation to sell, or any solicitation of any offer to purchase, nor shall it (or any part of it) or the fact of its distribution, form the basis of, or be relied on in connection with, any contract therefore. This press release must not be acted on or relied on in any member state of the European Economic Area by persons who are not Qualified Investors. Any investment or investment activity to which this press release relates is available only to Qualified Investors in any member state of the European Economic Area, and will be engaged in only with such persons.
|
|
|
